Showing results (21-30 of 28) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Investigational New Drugs|February 18, 2011
Phase 1 study of the novel vascular disrupting agent plinabulin (NPI-2358) and docetaxelMichael Millward, Paul Mainwaring, Alain Mita, et al.Bioorganic & Medicinal Chemistry Letters|September 3, 2003
Synthesis of a novel family of diterpenes and their evaluation as anti-inflammatory agentsThanh Lam, Taotao Ling, Chinmay Chowdhury, et al.Journal of Neural Transmission (Vienna, Austria : 1996)|November 24, 1998
Correlation of nicotinic binding with neurochemical markers in Alzheimer's diseaseM N Sabbagh, R T Reid, J Corey-Bloom, et al.Pharmaceutica Acta Helvetiae|May 17, 2000
Recombinant human receptors and functional assays in the discovery of altinicline (SIB-1508Y), a novel acetylcholine-gated ion channel (nAChR) agonistN D Cosford, L Bleicher, J M Vernier, et al.The Journal of Pharmacology and Experimental Therapeutics|January 1, 1997
Pharmacological characterization of SIB-1765F: a novel cholinergic ion channel agonistA I Sacaan, R T Reid, E M Santori, et al.Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Conformationally restricted analogues of nicotine and anabasineJ M Vernier, H Holsenback, N D Cosford, et al.Life Sciences|May 19, 1998
The potential of subtype-selective neuronal nicotinic acetylcholine receptor agonists as therapeutic agentsG K Lloyd, F Menzaghi, B Bontempi, et al.Current Cancer Drug Targets|January 21, 2011
Marizomib, a proteasome inhibitor for all seasons: preclinical profile and a framework for clinical trialsB C Potts, M X Albitar, K C Anderson, et al.Pageof 3